GSK brings Ramadhan bliss to HIV/AIDS children

Kuala Lumpur, 22 June 2018 – As a continuation of their ongoing partnership to reduce the impact of HIV/AIDS in Malaysia, GSK Pharmaceutical Sdn Bhd (GSK) and the Malaysian AIDS Foundation (MAF) came together this Ramadhan to bring happiness to children living with HIV/AIDS.

As a continuation of their ongoing partnership to reduce the impact of HIV/AIDS in Malaysia, GSK Pharmaceutical Sdn Bhd (GSK) and the Malaysian AIDS Foundation (MAF) came together this Ramadhan in a collective effort to bring happiness to children supported by the Paediatric AIDS Funds as part of their Orange Day programme.

The Paediatric AIDS Fund, an extension of MAF and supported by GSK Malaysia, provides monthly allowances of RM100 to 100 underprivileged children living with HIV or born into HIV-impacted families with a combined household income of less than RM2,000. These allowances help affected families to purchase necessities like food, household items and HIV care.

In 2009, GSK officially launched their Orange Day programme to give all employees one paid day off each year to volunteer for a good cause and this year, the two initiatives were combined to provide further support the fund recipients and their families during the holiday season.

“This year, GSK is celebrating 60 years of building healthier communities in Malaysia. In addition to our global portfolio dedicated to the eradication of HIV/AIDS, we are delighted to continue our commitment with our partners at MAF towards improving the lives of people living with HIV in our community” said Ramil Burden, Vice President and General Manager, GlaxoSmithKline Pharmaceutical Sdn Bhd, Malaysia

The initiative consisted of an array of activities including a charity Ramadhan Bazaar to raise funds for the children. Additionally, to give the children an opportunity to experience an authentic Hari Raya celebration, 30 GSK employees from the pharmaceutical and business service centre business units participated in the ‘Adopt a child for a day’ programme, whereby the children of the programme were accompanied in their Hari Raya shopping and treated to a special holiday outfit.

A buka puasa ceremony was also held for all the children that were fasting at Rumah Solehah, a home established by the Islamic Medical Association of Malaysia with the support of the Ministry of Health to provide women, children and orphans made vulnerable by HIV/AIDS medical, moral and spiritual support. The children then received duit raya, including a variety of GSK products such as Scott’s Emulsion and DHA Gummies in their goodie bags.

The Orange Day initiative is an extension from last year’s GSK Malaysia contribution of RM1.25 million for the Malaysian AIDS Foundation (MAF) to advance three of its high-impact AIDS programmes over the next three years.

“The Paediatric AIDS Fund is a vital component under the MAF umbrella of initiatives, acting as a support system for families and households with children living with or affected by HIV. This collaborative partnership with GSK Malaysia enables us to meet the basic needs of our beneficiaries to ensure they can live more positive lives, particularly around the festive season," said Professor Dato' Dr. Adeeba Kamarulzaman, Chairman of the Malaysian AIDS Foundation.

 “As a leading research based pharmaceutical company, we are committed to finding new medicines to treat HIV and work together with our strategic partners to reach the goal of ending AIDS by 2030,”Ramil Burden concluded.

-End-

About GlaxoSmithKline (GSK)

GSK – one of the world’s leading research-based pharmaceutical and healthcare companies – is committed to improving the quality of human life by enabling people to do more, feel better and live longer.  For further information on GSK Malaysia, please visit www.my.gsk.com.

Media Enquiries:

 

 

GSK

Lithika Sabat

014 722 7374

lithika.x.sabat@gsk.com

Edelman

Helen Sullivan

011 2840 3562

helen.sullivan@edelman.com

 

Haezell Alison Claudius

014 925 2504

haezell.alison@edelman.com

Trademarks are owned by or licensed to the GSK group of companies.